Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX1CA8
|
||||
Drug Name |
6-[4-(4-Acetyl-piperazin-1-yl)-phenoxymethyl]-7-(2-cyclohexyl-ethyl)-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile
|
||||
Synonyms |
CHEMBL481170
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C28H34N6O2
|
||||
Canonical SMILES |
CC(=O)N1CCN(CC1)c2ccc(OCc3cc4cnc(nc4n3CCC5CCCCC5)C#N)cc2
|
||||
InChI |
InChI=1S/C28H34N6O2/c1-21(35)32-13-15-33(16-14-32)24-7-9-26(10-8-24)36-20-25-17-23-19-30-27(18-29)31-28(23)34(25)12-11-22-5-3-2-4-6-22/h7-10,17,19,22H,2-6,11-16,20H2,1H3
|
||||
InChIKey |
SZVFURKQYHRIBV-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin K | Target Info | [1587926] | ||
Cathepsin L | Target Info | [1587926] | |||
Reactome | Collagen degradation | ||||
Degradation of the extracellular matrix | |||||
Activation of Matrix Metalloproteinases | |||||
Trafficking and processing of endosomal TLR | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentation | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.